Viewing nowDiphyton 10 mg (Dapagliflozin Propanediol Hydrate)
Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
Darim Biotech Co., Ltd.

MFDS item code 202300038 · Approved 2023.01.04 · Insurance code 664602780
Improves blood glucose in type 2 diabetes; prevents worsening of chronic heart failure and chronic kidney disease
This medication is used in conjunction with dietary and exercise therapies to help control blood sugar in patients with type 2 diabetes. It also helps reduce the risk of death and hospitalization from cardiovascular disease in patients with chronic heart failure. In patients with chronic kidney disease, it is effective in reducing the risk of kidney function decline and death from cardiovascular disease. This medication is used alongside other standard treatments for each condition to enhance therapeutic effect. Overall, it is beneficial in the treatment of diabetes, chronic heart failure, and chronic kidney disease.
Type 2 diabetes mellitus Monotherapy and add-on combination therapy The recommended dose of this medicine is 10mg once daily for monotherapy and add-on combination therapy with other glucose-lowering agents, such as insulin. When this medicine is used in combination with insulin or an insulin secretagogue such as a sulfonylurea, a lower dose of insulin or the insulin secretagogue may be considered to reduce the risk of hypoglycemia. Initial combination therapy For patients who have not previously received antidiabetic drug therapy, the recommended initial dose of this medicine when administered in combination with metformin is 5mg once daily or 10mg once daily. Chronic heart failure and chronic kidney disease The recommended dose of this medicine is 10 mg once daily. Special populations Renal impairment - eGFR less than 45 mL/min/1.73m2: Use of this medicine to improve glycemic control is not recommended. - eGFR less than 25 mL/min/1.73m2: Initiation of this medicine is not recommended in patients with chronic heart failure or chronic kidney disease. - Patients on dialysis: Do not administer this medicine. Hepatic impairment No dosage adjustment is necessary in patients with mild or moderate hepatic impairment. For patients with severe hepatic impairment, an initial dose of 5 mg is recommended. If well tolerated, this dose may be increased to 10mg. Elderly patients (≥ 65 years) Dosage adjustment based on age is not recommended. Method of administration This medicine may be administered orally once daily at any time of day, with or without food. Swallow the tablet whole.
The efficacy and safety of dapagliflozin in children under 18 years of age have not been established. No relevant data are available.
This medication should not be administered to certain patients. People with allergies to the active ingredients or excipients of this medication, type 1 diabetes patients, patients with diabetic ketoacidosis, individuals with genetic lactose intolerance, and patients undergoing dialysis should not use this medication. Caution should be exercised in patients with decreased fluid volume or impaired kidney function. In particular, patients with significantly impaired kidney function, the elderly, and those taking diuretics may be at increased risk for hypotension or kidney damage, so their condition should be closely monitored before and during administration. This medication may increase the risk of genital and urinary tract infections, so if symptoms of such infections appear, medical personnel should be informed immediately. When used with insulin or sulfonylureas that have a risk of hypoglycemia, hypoglycemic symptoms should be closely monitored, and if necessary, the dose of such medications should be adjusted. Due to the potential for dehydration or hypotension from decreased fluid volume, particularly elderly patients or those taking antihypertensive medications should regularly check their blood pressure and fluid status. This medication can cause a serious metabolic disorder known as diabetic ketoacidosis, so if symptoms such as vomiting, abdominal pain, or difficulty breathing occur, immediate medical care should be sought. Pregnant or breastfeeding women are advised not to use this medication, and if pregnancy is confirmed, administration should be immediately discontinued. In children, the safety and efficacy of dapagliflozin have not been sufficiently established, so it is not used. In case of overdose, there are no specific antidotes, but appropriate treatment is needed based on symptoms, and rapid treatment should be administered for dehydration or hypotension. Finally, this medication should be stored out of the reach of children and maintained in its original container to preserve quality.
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air and moisture, so it should be stored in a sealed container. Additionally, to maintain the drug's effectiveness, it is important to store it at a cool room temperature, specifically between 1 to 30 degrees Celsius.
Yellow, biconvex, diamond-shaped film-coated tablets
30 tablets/bottle, 100 tablets/bottle, 28 tablets/box[((7 tablets/Alu-Alu)×4)]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowDapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
Darim Biotech Co., Ltd.
Dapagliflozin Propanediol Hydrate 6.15mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.
Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
Donggu Bio Pharmaceutical Co., Ltd.
Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
Il Sung IS Co., Ltd.
Dapagliflozin Propanediol Hydrate
Prescription medication
Optus Pharmaceutical Co., Ltd.

Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
Aprogen Biologics Co., Ltd.

Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
Il Yang Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.